Other potent inhibitors of CYP3A4, such as itraconazole and HIV protease inhibitors, may be expected to have similar effects and similar dose reductions should therefore be applied.
Teised tugevad CYP3A4 inhibiitorid nagu näiteks itrakonasool ja proteaasi inhibiitorid on arvatavasti samasuguse toimega ja tingivad seetõttu samasuguse annuse vähendamise.